<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7190393\results\search\disease\results.xml">
  <result pre="the PMC Open Access Subset for unrestricted research re-use and" exact="secondary" post="analysis in any form or by any means with"/>
  <result pre="virus-host relationship is not set up to end with the" exact="complete" post="elimination of either or both. Pathogen-resistant individuals will always"/>
  <result pre="existential balance exists in the virus-host relationship. Against this backdrop," exact="viral" post="epidemics and pandemics only become manifest and egregious to"/>
  <result pre="we will concentrate on the facts currently available about severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2), which has caused COVID-19"/>
  <result pre="will concentrate on the facts currently available about severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2), which has caused COVID-19 (coronavirus"/>
  <result pre="concentrate on the facts currently available about severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2), which has caused COVID-19 (coronavirus disease"/>
  <result pre="respiratory syndrome coronavirus 2 (SARS-CoV-2), which has caused COVID-19 (coronavirus" exact="disease" post="2019) pandemic and try to predict its development and"/>
  <result pre="that SARS-CoV-2 will become as safe as the four non-severe" exact="acute" post="respiratory syndrome human coronaviruses (HCoV-NL63, HCoV-HKU1, HCoV-OC43, and HCoV-229E)"/>
  <result pre="SARS-CoV-2 will become as safe as the four non-severe acute" exact="respiratory" post="syndrome human coronaviruses (HCoV-NL63, HCoV-HKU1, HCoV-OC43, and HCoV-229E) currently"/>
  <result pre="will become as safe as the four non-severe acute respiratory" exact="syndrome" post="human coronaviruses (HCoV-NL63, HCoV-HKU1, HCoV-OC43, and HCoV-229E) currently circulating"/>
  <result pre="pangolin with the SARS-CoV-2 and evaluate the success of the" exact="infection" post="to determine the origin of the new virus responsible"/>
  <result pre="it come from animals or from a laboratory? While the" exact="absence of" post="disease symptoms in these animals may be due to"/>
  <result pre="from animals or from a laboratory? While the absence of" exact="disease" post="symptoms in these animals may be due to the"/>
  <result pre="to the effectiveness of their immune systems, the intensity of" exact="viral" post="proliferation can be easily detected using the real-time PCR"/>
  <result pre="the question about the origin of the virus. Obtaining related" exact="viral" post="sequences from animal sources would be the most definitive"/>
  <result pre="animal sources would be the most definitive way of revealing" exact="viral" post="origins [1]. The possibility of the existence of a"/>
  <result pre="origins [1]. The possibility of the existence of a potential" exact="intermediate" post="host of SARS-CoV-2, a missing link between a bat"/>
  <result pre="coronavirus [5]. In early December 2019, the first cases of" exact="pneumonia" post="of unknown origin were identified in Wuhan, the capital"/>
  <result pre="similarity to SARS-CoV [8], has been given the name severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2; also, COVID-19 virus). To"/>
  <result pre="to SARS-CoV [8], has been given the name severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2; also, COVID-19 virus). To date,"/>
  <result pre="SARS-CoV [8], has been given the name severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2; also, COVID-19 virus). To date, among"/>
  <result pre="coronavirus 2 (SARS-CoV-2; also, COVID-19 virus). To date, among the" exact="total" post="number of patients with COVID-19 globally, the case-fatality rate"/>
  <result pre="COVID-19 globally, the case-fatality rate (ratio between the dead and" exact="total" post="number of infected) ranges from 5.1 to 5.2% and"/>
  <result pre="Also, SARS-CoV-2 is supposed to be more contagious and environmentally" exact="stable" post="than seasonal flu viruses, since seasonal flu usually ends"/>
  <result pre="that the virus is also more likely to affect the" exact="heart" post="than any other similar viruses, so although pneumonia is"/>
  <result pre="affect the heart than any other similar viruses, so although" exact="pneumonia" post="is often the main cause of death, cardiologists and"/>
  <result pre="cardiac and many people infected with COVID-19 are dying from" exact="heart" post="attacks, as a possible complication of SARS-CoV-2 infection. High"/>
  <result pre="virus enters cells using its spike glycoprotein, was identified in" exact="type II" post="alveolar cells (AT2) of the lung [9â€&quot;11], esophagus upper"/>
  <result pre="in type II alveolar cells (AT2) of the lung [9â€&quot;11]," exact="esophagus" post="upper and stratified epithelial cells, absorptive enterocytes from the"/>
  <result pre="type II alveolar cells (AT2) of the lung [9â€&quot;11], esophagus" exact="upper" post="and stratified epithelial cells, absorptive enterocytes from the ileum"/>
  <result pre="cells (AT2) of the lung [9â€&quot;11], esophagus upper and stratified" exact="epithelial" post="cells, absorptive enterocytes from the ileum and colon [11],"/>
  <result pre="should be considered as a potential high risk for SARS-CoV-2" exact="infection" post="[9]. Investigations suggest that the spike glycoprotein of SARS-CoV-2"/>
  <result pre="in a small subset of cells in the lung called" exact="type 2" post="alveolar cells [8], are completely consistent between Pangolin CoV"/>
  <result pre="For the human population, this is the third significant coronavirus" exact="infection" post="to occur in the twenty-first century, following severe acute"/>
  <result pre="coronavirus infection to occur in the twenty-first century, following severe" exact="acute" post="respiratory syndrome (SARS) in 2002â€&quot;2003 and Middle East respiratory"/>
  <result pre="infection to occur in the twenty-first century, following severe acute" exact="respiratory" post="syndrome (SARS) in 2002â€&quot;2003 and Middle East respiratory syndrome"/>
  <result pre="to occur in the twenty-first century, following severe acute respiratory" exact="syndrome" post="(SARS) in 2002â€&quot;2003 and Middle East respiratory syndrome (MERS)"/>
  <result pre="severe acute respiratory syndrome (SARS) in 2002â€&quot;2003 and Middle East" exact="respiratory" post="syndrome (MERS) in 2011. Both SARS-CoV and MERS-CoV were"/>
  <result pre="acute respiratory syndrome (SARS) in 2002â€&quot;2003 and Middle East respiratory" exact="syndrome" post="(MERS) in 2011. Both SARS-CoV and MERS-CoV were newly"/>
  <result pre="of zoonotic origin in the genus Betacoronavirus, with a much" exact="lower" post="incidence than SARS-CoV-2: 8,096 cases for SARS since 2002"/>
  <result pre="is transmitted with enormous efficacy from human to human via" exact="respiratory" post="droplets or close contact. The highly contagious nature of"/>
  <result pre="were severe or critical [6, 17]. Most COVID-19 patients developed" exact="lymphopenia" post="and pneumonia, with characteristic pulmonary ground-glass opacity changes seen"/>
  <result pre="17]. Most COVID-19 patients developed lymphopenia and pneumonia, with characteristic" exact="pulmonary" post="ground-glass opacity changes seen on chest computed tomography [6,"/>
  <result pre="and pneumonia, with characteristic pulmonary ground-glass opacity changes seen on" exact="chest" post="computed tomography [6, 17, 18]. SARS-CoV-2 is believed to"/>
  <result pre="SARS-CoV-2 is believed to dampen anti-viral interferon responses resulting in" exact="uncontrolled" post="viral replication (for SARS-CoV and MERS-CoV, the response to"/>
  <result pre="is believed to dampen anti-viral interferon responses resulting in uncontrolled" exact="viral" post="replication (for SARS-CoV and MERS-CoV, the response to viral"/>
  <result pre="uncontrolled viral replication (for SARS-CoV and MERS-CoV, the response to" exact="viral infection" post="by type I IFN is suppressed). The influx of"/>
  <result pre="viral replication (for SARS-CoV and MERS-CoV, the response to viral" exact="infection" post="by type I IFN is suppressed). The influx of"/>
  <result pre="(for SARS-CoV and MERS-CoV, the response to viral infection by" exact="type I" post="IFN is suppressed). The influx of neutrophils and monocytes/macrophages"/>
  <result pre="cases of COVID-19 [6]. This so-called â€˜cytokine stormâ€™ can initiate" exact="viral" post="sepsis and inflammatory-induced lung injury, which lead to other"/>
  <result pre="inflammatory-induced lung injury, which lead to other complications including pneumonitis," exact="acute" post="respiratory distress syndrome (ARDS), respiratory failure, shock, organ failure,"/>
  <result pre="lung injury, which lead to other complications including pneumonitis, acute" exact="respiratory" post="distress syndrome (ARDS), respiratory failure, shock, organ failure, and"/>
  <result pre="which lead to other complications including pneumonitis, acute respiratory distress" exact="syndrome" post="(ARDS), respiratory failure, shock, organ failure, and potentially death"/>
  <result pre="to other complications including pneumonitis, acute respiratory distress syndrome (ARDS)," exact="respiratory" post="failure, shock, organ failure, and potentially death [19]. Individuals"/>
  <result pre="are elderly people with underlying diseases, including diabetes, hypertension, and" exact="cardiovascular disease" post="[6]. Since SARS-CoV-2 mutates constantly and more frequently than"/>
  <result pre="elderly people with underlying diseases, including diabetes, hypertension, and cardiovascular" exact="disease" post="[6]. Since SARS-CoV-2 mutates constantly and more frequently than"/>
  <result pre="so more errors are made when they are copied; also" exact="viral" post="RNA-dependent RNA polymerases do not have a proofreading nuclease"/>
  <result pre="patients with a severe course of the disease. As global" exact="infection" post="has progressed, we are now more frequently seeing young"/>
  <result pre="103 SARS-CoV-2 virus strains in GenBank, 101 of them exhibited" exact="complete" post="linkage between the two SNPs: 72 strains (~â€‰71%) exhibited"/>
  <result pre="virus-specific memory T-cells in broad and long-term protection against SARS-CoV" exact="infection" post="was elucidated [21, 22]. Indeed, the crucial protective role"/>
  <result pre="the crucial protective role of T-cell immune responses in coronavirus" exact="infections" post="has been clearly documented in several animal models, e.g.,"/>
  <result pre="has been clearly documented in several animal models, e.g., feline" exact="infectious" post="peritonitis virus (FIPV), mouse hepatitis virus (MHV), and avian"/>
  <result pre="been clearly documented in several animal models, e.g., feline infectious" exact="peritonitis" post="virus (FIPV), mouse hepatitis virus (MHV), and avian infectious"/>
  <result pre="several animal models, e.g., feline infectious peritonitis virus (FIPV), mouse" exact="hepatitis" post="virus (MHV), and avian infectious bronchitis virus (IBV) [23â€&quot;25]."/>
  <result pre="infectious peritonitis virus (FIPV), mouse hepatitis virus (MHV), and avian" exact="infectious" post="bronchitis virus (IBV) [23â€&quot;25]. Moreover, reinfection did not occur"/>
  <result pre="peritonitis virus (FIPV), mouse hepatitis virus (MHV), and avian infectious" exact="bronchitis" post="virus (IBV) [23â€&quot;25]. Moreover, reinfection did not occur in"/>
  <result pre="with other possible strains of people who recovered from initial" exact="infection" post="with one strain? At present, it remains unclear whether"/>
  <result pre="reinfection. It is also worth noting the theory that coronavirus" exact="infections" post="might play a part in multiple sclerosis. It is"/>
  <result pre="the theory that coronavirus infections might play a part in" exact="multiple sclerosis." post="It is known that mouse hepatitis virus, a murine"/>
  <result pre="a part in multiple sclerosis. It is known that mouse" exact="hepatitis" post="virus, a murine coronavirus, is a close relative of"/>
  <result pre="of common human coronavirus HCoV-OC43, which causes a multiple sclerosis-like" exact="demyelinating disease" post="in the central nervous system of rodents [27]. Some"/>
  <result pre="common human coronavirus HCoV-OC43, which causes a multiple sclerosis-like demyelinating" exact="disease" post="in the central nervous system of rodents [27]. Some"/>
  <result pre="HCoV-OC43, which causes a multiple sclerosis-like demyelinating disease in the" exact="central nervous system" post="of rodents [27]. Some studies have suggested that human"/>
  <result pre="that human coronaviruses, in particular HCoV-OC43, may be involved in" exact="gastrointestinal disease." post="Coronaviruses can be detected in stool samples, and antibodies"/>
  <result pre="to HCoV-OC43 have been observed more frequently in children with" exact="gastroenteritis" post="[28]. Thus, the future health of people who have"/>
  <result pre="to this virus (Fig.Â 1). This is one of the" exact="primary" post="reasons why pandemics of Spanish flu (H1N1 subtype) did"/>
  <result pre="is imperative to develop new vaccines and drugs against coronavirus" exact="infection" post="in case of emergency. Is it important today to"/>
  <result pre="emergency. Is it important today to stop the spread of" exact="infection" post="as quickly as possible? Yes, if possible, it must"/>
  <result pre="the human population has been able to completely obliterate a" exact="viral" post="disease by enacting successful anti-epidemiological measures, as happened with"/>
  <result pre="human population has been able to completely obliterate a viral" exact="disease" post="by enacting successful anti-epidemiological measures, as happened with the"/>
  <result pre="disease by enacting successful anti-epidemiological measures, as happened with the" exact="smallpox" post="virus [30], but smallpox virus had no animal reservoir."/>
  <result pre="anti-epidemiological measures, as happened with the smallpox virus [30], but" exact="smallpox" post="virus had no animal reservoir. Apparently, COVID-19 is not"/>
  <result pre="new coronavirus (as occurred with the four other well-known non-severe" exact="acute" post="respiratory syndrome (nonSARS)-related human coronaviruses (HCoVs), including HCoV-229E, -OC43,"/>
  <result pre="coronavirus (as occurred with the four other well-known non-severe acute" exact="respiratory" post="syndrome (nonSARS)-related human coronaviruses (HCoVs), including HCoV-229E, -OC43, -HKU1,"/>
  <result pre="(as occurred with the four other well-known non-severe acute respiratory" exact="syndrome" post="(nonSARS)-related human coronaviruses (HCoVs), including HCoV-229E, -OC43, -HKU1, and"/>
  <result pre="its place next to the seasonal flu viruses, where the" exact="infection" post="rate is high and the mortality rate is very"/>
  <result pre="the discovery of non-SARS HCoV-NL63 and HCoV-HKU1, several groups reported" exact="infections" post="by these viruses in different countries, illustrating that these"/>
  <result pre="The viruses can be detected in 1â€&quot;10% of patients with" exact="acute" post="respiratory tract infections, and double infections with other respiratory"/>
  <result pre="viruses can be detected in 1â€&quot;10% of patients with acute" exact="respiratory" post="tract infections, and double infections with other respiratory viruses"/>
  <result pre="1â€&quot;10% of patients with acute respiratory tract infections, and double" exact="infections" post="with other respiratory viruses are common [37]. Of note,"/>
  <result pre="with acute respiratory tract infections, and double infections with other" exact="respiratory" post="viruses are common [37]. Of note, for SARS-CoV, a"/>
  <result pre="Spike-coding regions, with possible recombination partners that include porcine epidemic" exact="diarrhea" post="virus (PEDV), transmissible gastroenteritis virus (TGEV), bovine coronavirus (BCoV),"/>
  <result pre="recombination partners that include porcine epidemic diarrhea virus (PEDV), transmissible" exact="gastroenteritis" post="virus (TGEV), bovine coronavirus (BCoV), HCoV-229E, MHV, and IBV"/>
  <result pre="SARS-CoV-2, through multiple recombination events, can trigger an outbreak of" exact="respiratory" post="diseases caused by new strains of nonSARS-related human HCoVs."/>
  <result pre="on washing hands frequently, avoiding crowds, and wearing masks are" exact="recurrent" post="in newspaper records and on websites, as is disdain"/>
  <result pre="who is at risk of a severe course of the" exact="disease" post="and who is not. Apparently, the bitter and unpopular"/>
  <result pre="a zugzwang situation: a greater number of deaths, or the" exact="collapse" post="of the global economy. We are on the second"/>
  <result pre="structural studies of SARSJ Virol202094711310.1128/JVI.00127-20 4.SheahanTet al.Mechanism of zoonotic severe" exact="acute" post="respiratory syndrome coronavirus host range expansion in human airway"/>
  <result pre="studies of SARSJ Virol202094711310.1128/JVI.00127-20 4.SheahanTet al.Mechanism of zoonotic severe acute" exact="respiratory" post="syndrome coronavirus host range expansion in human airway epitheliumJ"/>
  <result pre="of SARSJ Virol202094711310.1128/JVI.00127-20 4.SheahanTet al.Mechanism of zoonotic severe acute respiratory" exact="syndrome" post="coronavirus host range expansion in human airway epitheliumJ Virol2008822274228510.1128/JVI.02041-0718094188"/>
  <result pre="and receptor bindingLancet202039556557410.1016/S0140-6736(20)30251-832007145 8.ZhuNZhangDWangWet al.A novel coronavirus from patients with" exact="pneumonia" post="in China, 2019N Engl J Med202038272773310.1056/NEJMoa200101731978945 9.ZouXet al.The single-cell"/>
  <result pre="Sci202063345746010.1007/s11427-020-1637-532009228 15.GralinskiLEMenacheryVDReturn of the coronavirus: 2019-nCoVViruses.202010.3390/v1202013531991541 16.RotheCSchunkMSothmannPBretzelGFroeschlGWallrauchCet al.Transmission of 2019-nCoV" exact="infection" post="from an asymptomatic contact in GermanyN Engl J Med"/>
  <result pre="asymptomatic contact in GermanyN Engl J Med [Preprint]2020266210.1056/NEJMc2001468 17.ChanJFYuanSKokKHToKKChuHYangJet al.A" exact="familial" post="cluster of pneumonia associated with the 2019 novel coronavirus"/>
  <result pre="GermanyN Engl J Med [Preprint]2020266210.1056/NEJMc2001468 17.ChanJFYuanSKokKHToKKChuHYangJet al.A familial cluster of" exact="pneumonia" post="associated with the 2019 novel coronavirus indicating person-to-person transmission:"/>
  <result pre="a family clusterLancet202039551452310.1016/s0140-6736(20)30154-931986261 18.WuFZhaoSYuBChenYMWangWSongZGet al.A new coronavirus associated with human" exact="respiratory" post="disease in ChinaNature [Preprint]202057977981910.1038/s41586-020-2008-3 19.PrompetcharaEKetloyCPalagaTImmune responses in COVID-19 and"/>
  <result pre="family clusterLancet202039551452310.1016/s0140-6736(20)30154-931986261 18.WuFZhaoSYuBChenYMWangWSongZGet al.A new coronavirus associated with human respiratory" exact="disease" post="in ChinaNature [Preprint]202057977981910.1038/s41586-020-2008-3 19.PrompetcharaEKetloyCPalagaTImmune responses in COVID-19 and potential"/>
  <result pre="Rev202010.1186/s40779-020-00240-0 21.ZhaoCJZhaoJPerlmanST cell responses are required for protection from clinical" exact="disease" post="and for virus clearance in severe acute respiratory syndrome"/>
  <result pre="protection from clinical disease and for virus clearance in severe" exact="acute" post="respiratory syndrome coronavirus-infected miceJ Virol.201010.1128/JVI.01049-1021177821 22.ChannappanavarRFettCZhaoJMeyerholzDKPerlmanSVirus-specific memory CD8 T"/>
  <result pre="from clinical disease and for virus clearance in severe acute" exact="respiratory" post="syndrome coronavirus-infected miceJ Virol.201010.1128/JVI.01049-1021177821 22.ChannappanavarRFettCZhaoJMeyerholzDKPerlmanSVirus-specific memory CD8 T cells"/>
  <result pre="clinical disease and for virus clearance in severe acute respiratory" exact="syndrome" post="coronavirus-infected miceJ Virol.201010.1128/JVI.01049-1021177821 22.ChannappanavarRFettCZhaoJMeyerholzDKPerlmanSVirus-specific memory CD8 T cells provide"/>
  <result pre="memory CD8 T cells provide substantial protection from lethal severe" exact="acute" post="respiratory syndrome coronavirus infectionJ Virol201488110341104410.1128/JVI.01505-1425056892 23.LiHWangYHanZWangYLiangSJiangLHuYKongXLiuSRecombinant duck enteritis viruses"/>
  <result pre="CD8 T cells provide substantial protection from lethal severe acute" exact="respiratory" post="syndrome coronavirus infectionJ Virol201488110341104410.1128/JVI.01505-1425056892 23.LiHWangYHanZWangYLiangSJiangLHuYKongXLiuSRecombinant duck enteritis viruses expressing"/>
  <result pre="T cells provide substantial protection from lethal severe acute respiratory" exact="syndrome" post="coronavirus infectionJ Virol201488110341104410.1128/JVI.01505-1425056892 23.LiHWangYHanZWangYLiangSJiangLHuYKongXLiuSRecombinant duck enteritis viruses expressing major"/>
  <result pre="lethal severe acute respiratory syndrome coronavirus infectionJ Virol201488110341104410.1128/JVI.01505-1425056892 23.LiHWangYHanZWangYLiangSJiangLHuYKongXLiuSRecombinant duck" exact="enteritis" post="viruses expressing major structural proteins of the infectious bronchitis"/>
  <result pre="23.LiHWangYHanZWangYLiangSJiangLHuYKongXLiuSRecombinant duck enteritis viruses expressing major structural proteins of the" exact="infectious" post="bronchitis virus provide protection against infectious bronchitis in chickensAntivir"/>
  <result pre="duck enteritis viruses expressing major structural proteins of the infectious" exact="bronchitis" post="virus provide protection against infectious bronchitis in chickensAntivir Res2016130192610.1016/j.antiviral.2016.03.00326946113"/>
  <result pre="structural proteins of the infectious bronchitis virus provide protection against" exact="infectious" post="bronchitis in chickensAntivir Res2016130192610.1016/j.antiviral.2016.03.00326946113 24.TakanoCTTomizawaKMoriokaHDokiTHohdatsuTEvaluation of protective efficacy of"/>
  <result pre="proteins of the infectious bronchitis virus provide protection against infectious" exact="bronchitis" post="in chickensAntivir Res2016130192610.1016/j.antiviral.2016.03.00326946113 24.TakanoCTTomizawaKMoriokaHDokiTHohdatsuTEvaluation of protective efficacy of the"/>
  <result pre="containing the T-helper 1 epitope with CpG oligodeoxynucleotide against feline" exact="infectious" post="peritonitis virus infection in catsAntivir. Ther.201410.3851/IMP273524458025 25.TrujilloJAGrasSTwistKACroftNPChannappanavarRRossjohnJPurcellAWPerlmanSStructural and functional"/>
  <result pre="the T-helper 1 epitope with CpG oligodeoxynucleotide against feline infectious" exact="peritonitis" post="virus infection in catsAntivir. Ther.201410.3851/IMP273524458025 25.TrujilloJAGrasSTwistKACroftNPChannappanavarRRossjohnJPurcellAWPerlmanSStructural and functional correlates"/>
  <result pre="T-helper 1 epitope with CpG oligodeoxynucleotide against feline infectious peritonitis" exact="virus infection" post="in catsAntivir. Ther.201410.3851/IMP273524458025 25.TrujilloJAGrasSTwistKACroftNPChannappanavarRRossjohnJPurcellAWPerlmanSStructural and functional correlates of enhanced"/>
  <result pre="1 epitope with CpG oligodeoxynucleotide against feline infectious peritonitis virus" exact="infection" post="in catsAntivir. Ther.201410.3851/IMP273524458025 25.TrujilloJAGrasSTwistKACroftNPChannappanavarRRossjohnJPurcellAWPerlmanSStructural and functional correlates of enhanced"/>
  <result pre="Top Microbiol Immunol201841914210.1007/82_2017_2528643204 33.ArdenKENissenMDSlootsTPMackayIMNew human coronavirus, HCoV-NL63, associated with severe" exact="lower" post="respiratory tract disease in AustraliaJ Med Virol20057545546210.1002/jmv.2028815648064 34.BastienNAndersonKHartLVan CaeseelePBrandtKMilleyDHatchetteTWeissECLiYHuman"/>
  <result pre="Microbiol Immunol201841914210.1007/82_2017_2528643204 33.ArdenKENissenMDSlootsTPMackayIMNew human coronavirus, HCoV-NL63, associated with severe lower" exact="respiratory" post="tract disease in AustraliaJ Med Virol20057545546210.1002/jmv.2028815648064 34.BastienNAndersonKHartLVan CaeseelePBrandtKMilleyDHatchetteTWeissECLiYHuman coronavirus"/>
  <result pre="33.ArdenKENissenMDSlootsTPMackayIMNew human coronavirus, HCoV-NL63, associated with severe lower respiratory tract" exact="disease" post="in AustraliaJ Med Virol20057545546210.1002/jmv.2028815648064 34.BastienNAndersonKHartLVan CaeseelePBrandtKMilleyDHatchetteTWeissECLiYHuman coronavirus NL63 infection"/>
  <result pre="tract disease in AustraliaJ Med Virol20057545546210.1002/jmv.2028815648064 34.BastienNAndersonKHartLVan CaeseelePBrandtKMilleyDHatchetteTWeissECLiYHuman coronavirus NL63" exact="infection" post="in CanadaJ Infect Dis200519150350610.1086/42686915655772 35.ChiuSSChanKHChuKWKwanSWGuanYPoonLLPeirisJSHuman coronavirus NL63 infection and"/>
  <result pre="coronavirus NL63 infection in CanadaJ Infect Dis200519150350610.1086/42686915655772 35.ChiuSSChanKHChuKWKwanSWGuanYPoonLLPeirisJSHuman coronavirus NL63" exact="infection" post="and other coronavirus infections in children hospitalized with acute"/>
  <result pre="CanadaJ Infect Dis200519150350610.1086/42686915655772 35.ChiuSSChanKHChuKWKwanSWGuanYPoonLLPeirisJSHuman coronavirus NL63 infection and other coronavirus" exact="infections" post="in children hospitalized with acute respiratory disease in Hong"/>
  <result pre="NL63 infection and other coronavirus infections in children hospitalized with" exact="acute" post="respiratory disease in Hong KongChina Clin Infect Dis2005401721172910.1086/43030115909257 36.ChoiEHLeeHJKimSJEunBWKimNHLeeJALeeJHSongEKKimSHParkJYSungJYThe"/>
  <result pre="infection and other coronavirus infections in children hospitalized with acute" exact="respiratory" post="disease in Hong KongChina Clin Infect Dis2005401721172910.1086/43030115909257 36.ChoiEHLeeHJKimSJEunBWKimNHLeeJALeeJHSongEKKimSHParkJYSungJYThe association"/>
  <result pre="and other coronavirus infections in children hospitalized with acute respiratory" exact="disease" post="in Hong KongChina Clin Infect Dis2005401721172910.1086/43030115909257 36.ChoiEHLeeHJKimSJEunBWKimNHLeeJALeeJHSongEKKimSHParkJYSungJYThe association of"/>
  <result pre="Hong KongChina Clin Infect Dis2005401721172910.1086/43030115909257 36.ChoiEHLeeHJKimSJEunBWKimNHLeeJALeeJHSongEKKimSHParkJYSungJYThe association of newly identified" exact="respiratory" post="viruses with lower respiratory tract infections in Korean children,"/>
  <result pre="Infect Dis2005401721172910.1086/43030115909257 36.ChoiEHLeeHJKimSJEunBWKimNHLeeJALeeJHSongEKKimSHParkJYSungJYThe association of newly identified respiratory viruses with" exact="lower" post="respiratory tract infections in Korean children, 2000â€&quot;2005Clin Infect Dis20064358559210.1086/50635016886150"/>
  <result pre="Dis2005401721172910.1086/43030115909257 36.ChoiEHLeeHJKimSJEunBWKimNHLeeJALeeJHSongEKKimSHParkJYSungJYThe association of newly identified respiratory viruses with lower" exact="respiratory" post="tract infections in Korean children, 2000â€&quot;2005Clin Infect Dis20064358559210.1086/50635016886150 37.EbiharaTEndoRMaXIshiguroNKikutaHDetection"/>
  <result pre="association of newly identified respiratory viruses with lower respiratory tract" exact="infections" post="in Korean children, 2000â€&quot;2005Clin Infect Dis20064358559210.1086/50635016886150 37.EbiharaTEndoRMaXIshiguroNKikutaHDetection of human"/>
  <result pre="NL63 in young children with bronchiolitisJ Med Virol20057546346510.1002/jmv.2028915648061 38.EsperFWeibelCFergusonDLandryMLKahnJSCoronavirus HKU1" exact="infection" post="in the United StatesEmerg Infect Dis20061277577910.3201/eid1205.05131616704837 39.van der HoekLPyrcLKBerkhoutBHuman"/>
  <result pre="StatesEmerg Infect Dis20061277577910.3201/eid1205.05131616704837 39.van der HoekLPyrcLKBerkhoutBHuman coronavirus NL63, a new" exact="respiratory" post="virusFEMS Microbiol Rev20063076077310.1111/j.1574-6976.2006.00032.x16911043 40.ZhangXWYapYLDanchinATesting the hypothesis of a recombinant"/>
 </snippets>
</snippetsTree>
